RNR RenaissanceRe Holdings Ltd

RenaissanceRe Holdings is a global reinsurance company specializing in property catastrophe reinsurance and casualty and specialty reinsurance for complex risks. Sector: Financials.

RenaissanceRe Holdings Ltd (RNR) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 12.54%, WACC is 5.36%, and the economic spread is 7.18%. On balance, returns on capital just exceed funding costs, implying limited but real value creation at the margin. Supporting metrics show ROE at 22.07% and ROA at 4.99%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

On a multiple basis, the company trades at trailing P/E of 5.33, forward P/E of 7.94, PEG of 0.70. Forward P/E is broadly in line with trailing, suggesting analysts are not projecting a material change in profitability over the coming year. The PEG reading here is low enough to suggest investors are not being asked to overpay for the growth embedded in analyst estimates. The company carries a current ratio of 3.08, pointing to strong short-term financial health. The valuation setup is broadly consistent with a market that is pricing growth without being reckless about it — a balanced but not cautious stance.

The margin stack reads as follows: gross margin sits at 36.50%, operating margin at 32.25%, and free cash flow margin at 28.90%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. The company's FCF margin is a standout — reflecting businesses where accounting profits translate cleanly into real cash generation. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

The forward view combines two signals: the estimated 12-month price change of -0.79%, where analyst assumptions imply downside unless operating trends re-accelerate, while TTM revenue growth of 29.62% suggesting the company is collectively capturing meaningful market share or pricing power. The forward EPS growth estimate of -32.8% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.